Patents by Inventor Nathan Gianneschi

Nathan Gianneschi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230357575
    Abstract: In various embodiments, the present invention is directed to a supraparticle for use in producing structural colors comprising a plurality of core/shell nanoparticles having a melanin or synthetic melanin core and a silica shell having a plurality of silanol groups on its outer surface and a poly(ethylene glycol) (PEG) crosslinker. In various embodiments, the structure of these these crosslinked supra particles is reinforced by hydrogen bonds formed between the silanol groups on the core-shell nanoparticles and mechanical, solution phase, and dry state stability.
    Type: Application
    Filed: September 27, 2021
    Publication date: November 9, 2023
    Inventors: Ali DHINOJWALA, Nathan GIANNESCHI, Ming XIAO, Ziying HU
  • Publication number: 20230127548
    Abstract: Provided herein are methods of identifying a cell uptake modulator of a molecule that include (a) contacting a plurality of cells of a cell-containing biological sample with a plurality of gene-editing agents, wherein a gene-editing agent from the plurality of gene-editing agents recognizes and alters a target gene of at least one cell of the plurality of cells; (b) contacting the plurality of cells with a plurality of molecules, wherein at least one molecule of the plurality of molecules is transported into at least one cell of the plurality of cells; and (c) detecting a presence of the at least one molecule in the plurality of cells, thereby identifying the cell uptake modulator of the molecule.
    Type: Application
    Filed: September 28, 2022
    Publication date: April 27, 2023
    Inventors: Eugene Yeo, Eric Van Nostrand, Nathan Gianneschi, David A. Nelles, Sarah Barnhill, Anthony Rush
  • Publication number: 20230080523
    Abstract: In various embodiments, the present invention is directed to a facile one-pot reverse emulsion process to assemble core-shell nanoparticles (CS-SMNPs) into bright and noniridescent photonic supraballs. In one or more embodiments, the present invention is directed to core-shell nanoparticles having an inner high refractive index (RI) core and an outer low RI shell. In one or more embodiment, the present invention includes core-shell nanoparticles using high RI (˜1.74) melanin cores and low-RI (˜1.45) silica shells. In various embodiments, these nanoparticles may be self-assembled into bright and noniridescent supraballs using a scalable one-pot reverse emulsion process. According to various embodiments of the present invention, it is possible to generate a full spectrum of structural colors with the combination of only two ingredients, synthetic melanin and silica.
    Type: Application
    Filed: September 13, 2022
    Publication date: March 16, 2023
    Applicant: THE UNIVERSITY OF AKRON
    Inventors: Ali DHINOJWALA, Ming XIAO, Ziying HU, Matthew SHAWKEY, Nathan GIANNESCHI
  • Publication number: 20210301078
    Abstract: Provided herein are compositions and methods of making high density nucleic acid polymers.
    Type: Application
    Filed: February 10, 2021
    Publication date: September 30, 2021
    Applicant: The Regents of the University of California
    Inventors: Anthony M. RUSH, Nathan GIANNESCHI, Carrie JAMES
  • Patent number: 11072681
    Abstract: Provided herein are compositions and methods of making high density nucleic acid polymers.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: July 27, 2021
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Anthony M. Rush, Nathan Gianneschi, Carrie James
  • Publication number: 20200046859
    Abstract: The present disclosure generally provides compounds useful as MRI contrast agents. In some aspects, the disclosure provides MRI contrast agents that are chemically modified to have one or more moieties that include hydrophobic portions. In some aspects, the disclosure provides compositions that include such modified MRI contrast agents and a protein, such as albumin or albumin mimetics. Further, the disclosure provides various uses of these compounds and compositions.
    Type: Application
    Filed: April 25, 2018
    Publication date: February 13, 2020
    Inventors: Clare L.M. Leguyader, Nathan Gianneschi, Cassandra E. Callmann, Matthew P. Thompson, Treffly Ditri, Paul A. Bertin
  • Publication number: 20190275491
    Abstract: In various embodiments, the present invention is directed to a facile one-pot reverse emulsion process to assemble core-shell nanoparticles (CS-SMNPs) into bright and noniridescent photonic supraballs. In one or more embodiments, the present invention is directed to core-shell nanoparticles having an inner high refractive index (RI) core and an outer low RI shell. In one or more embodiment, the present invention includes core-shell nanoparticles using high RI (˜1.74) melanin cores and low-RI (˜1.45) silica shells. In various embodiments, these nanoparticles may be self-assembled into bright and noniridescent supraballs using a scalable one-pot reverse emulsion process. According to various embodiments of the present invention, it is possible to generate a full spectrum of structural colors with the combination of only two ingredients, synthetic melanin and silica.
    Type: Application
    Filed: November 22, 2017
    Publication date: September 12, 2019
    Inventors: Ali DHINOJWALA, Ming XIAO, Ziying HU, Matthew SHAWKEY, Nathan GIANNESCHI
  • Patent number: 10046057
    Abstract: There are disclosed compositions and methods to render nucleic acids resistant to nuclease digestion while maintaining sequence selective hybridization competency. The approach relies on utilizing nucleic acids as the polar head group of a nucleic acid-polymer amphiphile in order to assemble well-defined, discrete micellar nanoparticles. Dense packing of nucleic acid in the micelle corona allows for hybridization of complementary oligonucleotides while prohibiting enzymatic degradation.
    Type: Grant
    Filed: March 24, 2015
    Date of Patent: August 14, 2018
    Assignee: The Regents of the University of California
    Inventors: Erick T. Tatro, Nathan Gianneschi, Anthony M. Rush
  • Publication number: 20180169275
    Abstract: Described herein, inter alia, are compositions and methods for using polymeric micellar nanoparticles for nuclear magnetic resonance imaging in a subject in need thereof.
    Type: Application
    Filed: June 22, 2016
    Publication date: June 21, 2018
    Inventors: Nathan GIANNESCHI, Yiwen LI, Yuran HUANG, Miriam SCADENG
  • Publication number: 20170327633
    Abstract: Provided herein are compositions and methods of making high density nucleic acid polymers.
    Type: Application
    Filed: July 28, 2015
    Publication date: November 16, 2017
    Inventors: Anthony M. Rush, Nathan Gianneschi, Carrie James
  • Publication number: 20150190525
    Abstract: There are disclosed compositions and methods to render nucleic acids resistant to nuclease digestion while maintaining sequence selective hybridization competency. The approach relies on utilizing nucleic acids as the polar head group of a nucleic acid-polymer amphiphile in order to assemble well-defined, discrete micellar nanoparticles. Dense packing of nucleic acid in the micelle corona allows for hybridization of complementary oligonucleotides while prohibiting enzymatic degradation.
    Type: Application
    Filed: March 24, 2015
    Publication date: July 9, 2015
    Inventors: Erick T. Tatro, Nathan Gianneschi, Anthony M. Rush